Literature DB >> 9403276

Who cares about pharmacovigilance?

I R Edwards1.   

Abstract

Mesh：

Year:  1997        PMID： 9403276     DOI： 10.1007/s002280050342

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Spontaneous reporting--of what? Clinical concerns about drugs.

Authors:  I R Edwards
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world.

Authors:  Rohini B M Fernandopulle; Krisantha Weerasuriya
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Recent news about drug risks: application to Canadians.

Authors:  V Hogan; C Turner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

4.  Discontinuation reactions associated with SSRIs.

Authors:  L Macdonald
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 5.  A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators.

Authors:  Hamza Y Garashi; Douglas T Steinke; Ellen I Schafheutle
Journal:  Ther Innov Regul Sci       Date:  2022-06-03       Impact factor: 1.337

Review 6.  Pharmacovigilance in Italy: An overview.

Authors:  Carmela Mazzitello; Stefania Esposito; Adele E De Francesco; Annalisa Capuano; Emilio Russo; Giovambattista De Sarro
Journal:  J Pharmacol Pharmacother       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.